Apathy: Clinical Trials

9 trials for Apathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 recruiting, 2 not yet recruiting, 1 unknown. 9 Phase 2, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 29Completed 3, Recruiting 3, Not yet recruiting 2, Unknown 1
Phase 13Recruiting 2, Not yet recruiting 1

Follow Apathy: new trials by email Literature Review of Apathy trials Research Report on Apathy

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
IRL757, Placebo - PARKINSON DISEASE (Disorder), Apathy
Phase 1 / Phase 2RecruitingIntegrative Research Laboratories AB752026-02-182026-09-03
Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia
intermittent theta burst stimulation (iTBS), Methylphenidate (MPH) - Alzheimer s Disease, Alzheimer Dementia (AD)
Phase 2RecruitingSunnybrook Health Sciences Centre122026-01-012025-12-12
Accelerated rTMS vs. Sham for Stroke Apathy
MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Active), MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Sham), Brainsight Neuronavigation System - Apathy, Stroke
Phase 1 / Phase 2RecruitingMedical University of South Carolina402025-08-082026-07-08
Effort and Antidepressant Study Test
Escitalopram 10mg, Placebo 10 mg - Effort Based Decision Making, Prosocial Behavior
Phase 1 / Phase 2Not yet recruitingUniversity of Oxford502025-01-012024-11-20
Methylphenidate for Apathy in Veterans With Parkinson's Disease
Psychosocial intervention, Methylphenidate - Parkinson Disease, Apathy
Phase 2Not yet recruitingRalph H. Johnson VA Medical Center602024-01-012022-12-30
Repetitive Transcranial Magnetic Stimulation for Apathy Treatment in Alzheimer's Disease
Magnetic Stimulator Magstim Rapid 2, Sham Magnetic Stimulator - Alzheimer's Disease, Apathy
Phase 2UnknownFederal University of Minas Gerais402013-06-012013-06-25
Apathy Cure Through Bupropion in Huntington's Disease
Bupropion, Placebo - Apathy, Huntington's Disease
Phase 2CompletedCharite University, Berlin, Germany402012-06-012014-09-09
Effects of Transcranial Direct Current Stimulation on the Apathy of Alzheimer's Disease
Transcranial direct current stimulation - Apathy, Alzheimer's Disease
Phase 2CompletedUniversity of Sao Paulo402012-01-012014-01-09
Apathy in Dementia Methylphenidate Trial (ADMET)
Methylphenidate, placebo, Psychosocial intervention - Apathy, Alzheimer's Disease
Phase 2CompletedJohns Hopkins Bloomberg School of Public Health602010-06-012018-06-12

Narrower conditions

Lethargy (9)  ·  Alzheimer Disease (4)  ·  Dementia (3)  ·  Parkinson Disease (2)  ·  Altruism (1)  ·  Depression (1)  ·  Huntington Disease (1)  ·  Ischemia (1)  ·  Stroke (1)

Broader conditions

Nervous System Diseases (9)  ·  Neurobehavioral Manifestations (9)  ·  Neurologic Manifestations (9)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Signs and Symptoms (9)  ·  Brain Diseases (8)  ·  Central Nervous System Diseases (8)  ·  Neurodegenerative Diseases (7)  ·  Mental Disorders (5)  ·  Neurocognitive Disorders (5)  ·  Tauopathies (4)  ·  Basal Ganglia Diseases (3)  ·  Movement Disorders (3)  ·  Behavior (2)  ·  Dementia (2)

Interventions

Methylphenidate (3)  ·  Psychosocial Intervention (2)  ·  Bupropion (1)  ·  Drug Delivery Systems (1)  ·  Escitalopram (1)  ·  Transcranial Direct Current Stimulation (1)  ·  Transcranial Magnetic Stimulation (1)

Sponsors

Charite University, Berlin, Germany (1)  ·  Federal University of Minas Gerais (1)  ·  Integrative Research Laboratories AB (1)  ·  Johns Hopkins Bloomberg School of Public Health (1)  ·  Medical University of South Carolina (1)  ·  Ralph H. Johnson VA Medical Center (1)  ·  Sunnybrook Health Sciences Centre (1)  ·  University of Oxford (1)  ·  University of Sao Paulo (1)

Countries

Brazil (2)  ·  Canada (2)  ·  Germany (2)  ·  United States (2)  ·  Bulgaria (1)  ·  Poland (1)  ·  Spain (1)

Top investigators

Krista Lanctot, PhD (2)  ·  Breno S Diniz, MD, PhD (1)  ·  Catherine J Harmer, PhD (1)  ·  Claudia K Suemoto, MD, PhD (1)  ·  Ester Nakamura-Palacios, MD, PhD (1)  ·  Felipe Fregni, MD, PhD, MPH (1)  ·  Jacobo Mintzer, MD, MBA (1)  ·  Josef Priller, MD (1)  ·  Kevin Caulfield, PhD (1)  ·  Lisa McTeague, PhD (1)  ·  Parneet Grewal, PhD (1)  ·  Paul Rosenberg, MD (1)  ·  Ricardo Nitrini, MD, PhD (1)  ·  Roberta Scherer, PhD (1)

Results publications

PMID 24021498, PMID 24262299

NIH funding

2009 (1), R01AG033032 (1)